Small Lymphocytic Lymphoma — Trials

Small Lymphocytic Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

479 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 129
Recruiting: 67
Ph III recruiting: 9
Growth YoY: −23.8%
Industry share: 37%
Top sponsor: National Cancer Institute (NCI)
Termination share: 41.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (108)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07428707	Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib	recruiting	Early Phase 1	30	National Heart, Lung, and Blood Institute (NHLBI)NIH	1	Aug 21, 2026	clinicaltrials
NCT06636175	64Cu-LLP2A for Imaging Hematologic Malignancies	recruiting	Early Phase 1	42	Washington University School of MedicineOTHER	1	Jun 17, 2026	clinicaltrials